ITPD20020138A0 - Composizione di sostanze a base terpenica, metodo di preparazione e metodo di dispersione in ambiente della medesima. - Google Patents

Composizione di sostanze a base terpenica, metodo di preparazione e metodo di dispersione in ambiente della medesima.

Info

Publication number
ITPD20020138A0
ITPD20020138A0 IT2002PD000138A ITPD20020138A ITPD20020138A0 IT PD20020138 A0 ITPD20020138 A0 IT PD20020138A0 IT 2002PD000138 A IT2002PD000138 A IT 2002PD000138A IT PD20020138 A ITPD20020138 A IT PD20020138A IT PD20020138 A0 ITPD20020138 A0 IT PD20020138A0
Authority
IT
Italy
Prior art keywords
terpene
dispersion
environment
preparation
composition
Prior art date
Application number
IT2002PD000138A
Other languages
English (en)
Inventor
Matteo Bevilacqua
Original Assignee
Matteo Bevilacqua
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matteo Bevilacqua filed Critical Matteo Bevilacqua
Priority to IT2002PD000138A priority Critical patent/ITPD20020138A1/it
Publication of ITPD20020138A0 publication Critical patent/ITPD20020138A0/it
Priority to EP03755117A priority patent/EP1507545A1/en
Priority to PCT/EP2003/005412 priority patent/WO2003099302A1/en
Priority to US10/515,656 priority patent/US20060222723A1/en
Priority to AU2003242563A priority patent/AU2003242563A1/en
Priority to JP2004506826A priority patent/JP2005533767A/ja
Publication of ITPD20020138A1 publication Critical patent/ITPD20020138A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Psychiatry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Virology (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Addiction (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
IT2002PD000138A 2002-05-24 2002-05-24 Composizione di sostanze a base terpenica, metodo di preparazione e metodo di dispersione in ambiente della medesima. ITPD20020138A1 (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT2002PD000138A ITPD20020138A1 (it) 2002-05-24 2002-05-24 Composizione di sostanze a base terpenica, metodo di preparazione e metodo di dispersione in ambiente della medesima.
EP03755117A EP1507545A1 (en) 2002-05-24 2003-05-23 A terpene-based composition of substances, a method for its preparation and a method for its dispersal into the atmosphere
PCT/EP2003/005412 WO2003099302A1 (en) 2002-05-24 2003-05-23 A terpene-based composition of substances, a method for its preparation and a method for its dispersal into the atmosphere
US10/515,656 US20060222723A1 (en) 2002-05-24 2003-05-23 Terpene-based composition of substances, a method for its preparation and a method for its dispersal into the atmosphere
AU2003242563A AU2003242563A1 (en) 2002-05-24 2003-05-23 A terpene-based composition of substances, a method for its preparation and a method for its dispersal into the atmosphere
JP2004506826A JP2005533767A (ja) 2002-05-24 2003-05-23 テルペン基材組成物、その調製方法および大気散布方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002PD000138A ITPD20020138A1 (it) 2002-05-24 2002-05-24 Composizione di sostanze a base terpenica, metodo di preparazione e metodo di dispersione in ambiente della medesima.

Publications (2)

Publication Number Publication Date
ITPD20020138A0 true ITPD20020138A0 (it) 2002-05-24
ITPD20020138A1 ITPD20020138A1 (it) 2003-11-24

Family

ID=11452532

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2002PD000138A ITPD20020138A1 (it) 2002-05-24 2002-05-24 Composizione di sostanze a base terpenica, metodo di preparazione e metodo di dispersione in ambiente della medesima.

Country Status (6)

Country Link
US (1) US20060222723A1 (it)
EP (1) EP1507545A1 (it)
JP (1) JP2005533767A (it)
AU (1) AU2003242563A1 (it)
IT (1) ITPD20020138A1 (it)
WO (1) WO2003099302A1 (it)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10331750A1 (de) * 2003-07-14 2005-02-10 Keyneurotek Ag Verwendung der Hydrierungsprodukte von Weihrauch (Olibanum) zur Prophylaxe und/oder Behandlung von zerebraler Ischämie, Schädel/Hirntrauma und/oder Alzheimer-Krankheit
ITMI20031390A1 (it) * 2003-07-08 2005-01-09 Turispharma S R L Metodo di estrazione di strutture molecolari attive da resine naturali e/o da oli essenziali.
US7914813B2 (en) * 2004-02-03 2011-03-29 Hisamitsu Pharmaceutical Co., Inc. Interface for transdermal drug administration device
US7871377B2 (en) * 2005-01-21 2011-01-18 Aveda Corporation Method of evaluating human subconscious response to smell
US20060269567A1 (en) * 2005-05-16 2006-11-30 Liu Yuen Universal detoxifying composition
JP4918259B2 (ja) * 2006-01-06 2012-04-18 株式会社キャタラー 低分子有機ガス吸収材及びこれを用いた燃料蒸気処理装置
JP2007332126A (ja) * 2006-06-16 2007-12-27 Teikyo Univ ヒトおよび愛玩動物のための抗白癬入浴剤
WO2008017280A1 (de) * 2006-08-10 2008-02-14 Franz Udo Willerscheidt Soporus; sedativum mit myrrhe und süssholzwurzel
WO2009117987A2 (de) * 2008-03-26 2009-10-01 Universität Tübingen Verwendung von boswelliasäuren und synthetischen boswelliasäurederivaten zur hemmung der mikrosomalen prostaglandin e2 synthase und des cathepsin g
GB2471523A (en) 2009-07-03 2011-01-05 Gw Pharma Ltd Use of tetrahydrocannibivarin (THCV) and optionally cannabidiol (CBD) in the treatment of epilepsy
AU2010310946A1 (en) * 2009-10-28 2012-05-17 Regenera Pharma Ltd. Therapeutic uses of oligomeric and polymeric monoterpenes
TWI583374B (zh) * 2010-03-30 2017-05-21 Ｇｗ伐瑪有限公司 使用植物***素次***二酚（ｃｂｄｖ）來治療癲癇之用途
CN102670689A (zh) * 2011-03-14 2012-09-19 苏州博创园生物医药科技有限公司 治疗银屑病喷雾剂的制备方法
GB2495118B (en) 2011-09-29 2016-05-18 Otsuka Pharma Co Ltd A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
CN102670740B (zh) * 2012-05-28 2014-01-15 石家庄平安医院有限公司 一种治疗软组织损伤的药物组合物及其制备方法
ITPD20120343A1 (it) * 2012-11-13 2014-05-14 Matteo Bevilacqua Composto in particolare per la cura della depressione e dell'ansia
GB2530001B (en) 2014-06-17 2019-01-16 Gw Pharma Ltd Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy
GB2527599A (en) 2014-06-27 2015-12-30 Gw Pharma Ltd Use of 7-OH-Cannabidiol (7-OH-CBD) and/or 7-OH-Cannabidivarin (7-OH-CBDV) in the treatment of epilepsy
GB2531282A (en) 2014-10-14 2016-04-20 Gw Pharma Ltd Use of cannabinoids in the treatment of epilepsy
GB2531281A (en) 2014-10-14 2016-04-20 Gw Pharma Ltd Use of cannabidiol in the treatment of intractable epilepsy
GB2531278A (en) 2014-10-14 2016-04-20 Gw Pharma Ltd Use of cannabidiol in the treatment of intractable epilepsy
CN104491458B (zh) * 2015-01-08 2017-09-19 魏财禧 一种中药外用药及其制备方法与应用
GB2539472A (en) 2015-06-17 2016-12-21 Gw Res Ltd Use of cannabinoids in the treatment of epilepsy
GB2541191A (en) 2015-08-10 2017-02-15 Gw Pharma Ltd Use of cannabinoids in the treatment of epilepsy
GB2548873B (en) 2016-03-31 2020-12-02 Gw Res Ltd Use of Cannabidiol in the Treatment of SturgeWeber Syndrome
GB2551987A (en) 2016-07-01 2018-01-10 Gw Res Ltd Oral cannabinoid formulations
GB2551986A (en) 2016-07-01 2018-01-10 Gw Res Ltd Parenteral formulations
GB2553139A (en) 2016-08-25 2018-02-28 Gw Res Ltd Use of cannabinoids in the treatment of multiple myeloma
GB2557921A (en) 2016-12-16 2018-07-04 Gw Res Ltd Use of cannabinoids in the treatment of angelman syndrome
WO2018148152A1 (en) * 2017-02-07 2018-08-16 Wayne Green Terpene-based compositions, methods of preparations and uses thereof
GB2559774B (en) 2017-02-17 2021-09-29 Gw Res Ltd Oral cannabinoid formulations
CN107296896B (zh) * 2017-06-28 2020-06-30 高康日化集团有限公司 一种治疗胶质瘤的药物组合物及其制备方法
CN107519322B (zh) * 2017-10-20 2021-01-05 葛洪伟 通过泄殖腔给药方式防治母鸡输卵管炎的中药喷剂
GB2569961B (en) 2018-01-03 2021-12-22 Gw Res Ltd Pharmaceutical
KR20200118084A (ko) * 2018-02-08 2020-10-14 네온씨 테크놀로지스, 아이엔씨. 혈액 뇌 장벽의 투과 방법
CN115298246A (zh) * 2020-01-14 2022-11-04 P2科学公司 聚醚聚合物的连位二醇醚衍生物
GB202002754D0 (en) 2020-02-27 2020-04-15 Gw Res Ltd Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
US11160757B1 (en) 2020-10-12 2021-11-02 GW Research Limited pH dependent release coated microparticle cannabinoid formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57179101A (en) * 1981-04-27 1982-11-04 Lion Corp Repellent for bloodsucking vermin
US4826686A (en) * 1985-12-14 1989-05-02 Boehringer Ingelheim Kg Therapeutic system
JPH0551301A (ja) * 1991-08-23 1993-03-02 Osaka Gas Co Ltd 防菌・防黴性香気発生具
US5629351A (en) * 1995-04-13 1997-05-13 Council Of Scientific & Industrial Research Boswellic acid compositions and preparation thereof
US6077513A (en) * 1996-05-02 2000-06-20 Massoud; Ahmed Mohamed Ali Drug for treatment of bilharziasis (Schistosomiasis)

Also Published As

Publication number Publication date
ITPD20020138A1 (it) 2003-11-24
EP1507545A1 (en) 2005-02-23
US20060222723A1 (en) 2006-10-05
JP2005533767A (ja) 2005-11-10
AU2003242563A1 (en) 2003-12-12
WO2003099302A1 (en) 2003-12-04

Similar Documents

Publication Publication Date Title
ITPD20020138A0 (it) Composizione di sostanze a base terpenica, metodo di preparazione e metodo di dispersione in ambiente della medesima.
NO20055018D0 (no) Anti-amyolide antistoffer, sammensetninger, fremgangsmater og anvendelser
DE60317699D1 (de) Fermentationsverfahren und -zusammensetzungen
NO20032830L (no) Tetrahydropyridinderivater, fremstilling derav og anvendelse som celleproliferasjonsinhibitorer
ITRM20020411A1 (it) Derivati dello spirobifluorene, loro preparazione e loro uso.
DE60305611D1 (de) Tonzusammensetzung, Verfahren und Anwendungen damit
DK1511734T3 (da) Forbindelser, præparater og fremgangsmåder
IL169366A0 (en) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
AU2003207199A1 (en) Structure, method of manufacturing the same, and device using the same
AU2003297079A1 (en) Anti-filming materials, compositions and methods
BR0312460B1 (pt) suporte sàlido, processo de preparaÇço, e, uso do mesmo.
AU2003251167A1 (en) Solid dispersion comprising amlodipine, method thereof and pharmaceutical composition comprising the solid dispersion
WO2004003149A8 (en) Cngh0005 polypeptides, antibodies, compositions, methods and uses
DE602004018320D1 (de) N-ä3-(3-substituierte pyrazoloä1,5-aüpyrimidin-7-yl)phenylü-sulfonamide, und zusammensetzungen, und damit in zusammenhang stehende verfahren
IL169360A0 (en) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
ITRM20010116A0 (it) Indicatore goniometricoastronomico, in particolare solare e/o lunare.
AU2002353163A1 (en) Scatterometry structure with embedded ring oscillator, and methods of using same
NO20055142D0 (no) Diarylmetylidenpiperidinderivater, fremstillinger og anvendelser derav
DK1483220T3 (da) Lette bröndcementsammensætninger og fremgangsmåder
ITMI20031659A1 (it) Visualizzatore e procedimento di fabbricazione.
AU2003238965A1 (en) Methods for using adamts-12, an integrin and metalloprotease with thrombospondin motifs
ITMI20022425A1 (it) Distanziatore e distanziale.
EP1618125A4 (en) Vitamin C derivatives with peptide, process for their preparation and composition containing them
FI20031065A (fi) Hyönteissuoja-aine, menetelmä sen valmistamiseksi ja sen käyttö
DE60314203D1 (de) Einzelphotonemissionsverfahren, Halbleitervorrichtung und dessen Herstellungsverfahren